Category Archives: Int’l Practice and Policy

Important Amendments to Chinese Patent Law

Guest post from Deshan Li, Ph.D., Executive Vice President and Senior Partner at Unitalen Attorneys at Law. On October 17, 2020, the amendments to the Patent Law were adopted by the Congress, which will come into effect as of June … Continue reading

Posted in Int'l Practice and Policy, Uncategorized | Tagged , , | Leave a comment

IP Update – Canada | New Patent Rules released: 12 Notable Changes & Tips

Guest Post from David Schwartz and Jeff Leuschner of  Smart & Biggar. On December 1, 2018, the Canadian government released its proposed new Patent Rules in the Canada Gazette, Part I. This is one of the last steps necessary for implementing significant changes … Continue reading

Posted in Int'l Practice and Policy | Tagged , , , | Leave a comment

Do You Really Want to File for Pharma Patent Protection in Canada, India or Ecuador?

IPO Letter Reports Weaknesses in IP Protection Around the World In a 27 page letter dated February 8, 2018 and sent to Sue Chang at the Office of the U.S. Trade Representative, the Executive Director of IPO, Mark Lauroesch, extensively … Continue reading

Posted in Govt Policy/PTO Policy, Int'l Practice and Policy, Non-U.S. Practice | Tagged , , | 1 Comment

Canada’s ‘’Sister” Prior Art Law Differs From Ours, Eh!

I recently received a well-written post from Smart & Biggar/Feherstonhaugh in Toronto reminding me that a publication by the inventor only shields a later third-party publication from being a bar if the second publication was derived from the inventor and a … Continue reading

Posted in Int'l Practice and Policy | Tagged , , , , , , , | Leave a comment